Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
21.8M
-
Shares change
-
+5.84M
-
Total reported value, excl. options
-
$161M
-
Value change
-
+$48.5M
-
Put/Call ratio
-
0.66
-
Number of buys
-
56
-
Number of sells
-
-35
-
Price
-
$7.37
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q2 2020
102 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q2 2020.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.8M shares
of 134M outstanding shares and own 16.31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.91M shares), Consonance Capital Management LP (2.57M shares), BVF INC/IL (2.39M shares), VANGUARD GROUP INC (2.12M shares), FMR LLC (1.78M shares), STATE STREET CORP (736K shares), AXA (710K shares), Invesco Ltd. (676K shares), RENAISSANCE TECHNOLOGIES LLC (624K shares), and GEODE CAPITAL MANAGEMENT, LLC (588K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.